Graham K. Crooke

Dillon Read Capital Management is a New York City-based hedge fund boutique subsidiary of UBS Global Asset Management (Americas), Inc., itself a division of UBS AG (NYSE: UBS).

Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA.

Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA.

Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California.

InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.

iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA.

Biomimedica, Inc. develops medical devices to restore damaged joints. Its main focus is to treat degenerative disease of articular cartilage, which is called Osteoarthritis. The company was founded by David Myung and Lampros Kourtis in 2008 and is headquartered in Ripon, CA.

Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.